Your Search Results

CTO ADVANCED Level II: LIVE Educational Cases from Cleveland Clinic London, UK & University Hospital Basel, Switzerland

21 May 2026 – From EuroPCR 2026

This advanced session presents live educational cases on chronic total occlusions (CTO) from leading centers in London and Basel. Participants gain insights into selecting antegrade versus retrograde approaches, interpreting intravascular imaging for informed decision-making, and integrating sophisticated tools and techniques to enhance procedural success in complex...

CTO ADVANCED Level II: LIVE Educational Cases from Cleveland Clinic London, UK & University Hospital Basel, Switzerland

Calcified lesion of distal protected left main - LIVE case

22 May 2026 – From EuroPCR 2026

An 85‑year‑old man with type 2 diabetes mellitus, hypertension, dyslipidemia, peripheral artery disease, COPD, and chronic kidney disease presented with CCS class II angina related to three‑vessel coronary artery disease. He had previously undergone hybrid revascularization, including PCI of the RCA ostium and CABG with LIMA...

Calcified lesion of distal protected left main - LIVE case

Haemodynamic support: from shock to complex high-risk interventional problems

21 May 2026 – From EuroPCR 2026

This session examines haemodynamic support from cardiogenic shock through to complex high-risk interventional cardiology procedures. It features registry data, clinical outcomes, and procedural techniques including mechanical circulatory support and arterial access strategies.

TAVI complications - Prediction, reduction, avoidance

21 May 2026 – From EuroPCR 2026

This session examines prediction, reduction, and avoidance of complications associated with TAVI procedures. It covers outcomes of second-valve implantation as a bail-out for valve migration, predictors of permanent pacemaker implantation post-TAVI from the LANDMARK trial, neurological event prognostics based on timing, and management of periprocedural cardiac...

TAVI complications - Prediction, reduction, avoidance

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.